These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 11550308

  • 41. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y, Ng HK, Ding M, Zhang SF, Pang JC, Lo KW.
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T.
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [Abstract] [Full Text] [Related]

  • 44. Genetic analysis of a multifocal glioblastoma multiforme: a suitable tool to gain new aspects in glioma development.
    Krex D, Mohr B, Appelt H, Schackert HK, Schackert G.
    Neurosurgery; 2003 Dec; 53(6):1377-84; discussion 1384. PubMed ID: 14633303
    [Abstract] [Full Text] [Related]

  • 45. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
    von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yaşargil MG, Wiestler OD.
    J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666
    [Abstract] [Full Text] [Related]

  • 46. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H, Kleihues P.
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
    [Abstract] [Full Text] [Related]

  • 47. Progression as exemplified by human astrocytic tumors.
    Collins VP.
    Semin Cancer Biol; 1999 Aug; 9(4):267-76. PubMed ID: 10448114
    [Abstract] [Full Text] [Related]

  • 48. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H.
    Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
    [Abstract] [Full Text] [Related]

  • 49. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 50. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 51. Genetic pathways to glioblastoma: a population-based study.
    Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P.
    Cancer Res; 2004 Oct 01; 64(19):6892-9. PubMed ID: 15466178
    [Abstract] [Full Text] [Related]

  • 52. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
    Tortosa A, Ino Y, Odell N, Swilley S, Sasaki H, Louis DN, Henson JW.
    Neuropathol Appl Neurobiol; 2000 Dec 01; 26(6):544-52. PubMed ID: 11123721
    [Abstract] [Full Text] [Related]

  • 53. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
    Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD.
    Am J Pathol; 1999 Aug 01; 155(2):375-86. PubMed ID: 10433931
    [Abstract] [Full Text] [Related]

  • 54. Alterations of cell cycle regulators in gliomatosis cerebri.
    Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Deimling A, Stoltenburg-Didinge G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K.
    J Neurooncol; 2005 Apr 01; 72(2):115-22. PubMed ID: 15925990
    [Abstract] [Full Text] [Related]

  • 55. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
    Feng T, Liu Y, Li C, Li Z, Cai H.
    Tumour Biol; 2017 Jul 01; 39(7):1010428317716248. PubMed ID: 28670979
    [Abstract] [Full Text] [Related]

  • 56. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A, Ehrmann J, Sedlakova E, Krejci V, Knizetova P, Fiuraskova M, Kala M, Kalita O, Kolar Z.
    Neoplasma; 2007 Jul 01; 54(4):334-41. PubMed ID: 17822324
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr 01; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 59. Molecular biology of malignant degeneration of astrocytoma.
    Furnari FB, Huang HJ, Cavenee WK.
    Pediatr Neurosurg; 1996 Apr 01; 24(1):41-9. PubMed ID: 8817614
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.